Trabeculostomy As A New Effective Surgery For Glaucoma
Published 2023 - 41st Congress of the ESCRS
Reference: PO0874 | DOI: 10.82333/8bh9-ny18
Authors: Lilit Albert Voskanyan* 1 , Hovsep Miroyan 2 , Astghik Ghazaryan 3 , Haik Babayan 3 , Vahan Papoyan 3
1Glaucoma, Chief of Dept,S.V.Malayan's Eye Cente, Yerevan State Medical University,Yerevan,Armenia, 2Director,S.V.Malayan's Eye Cente,Yerevan,Armenia, 3Glaucoma,S.V.Malayan's Eye Cente,Yerevan,Armenia
To report the short-term (6 months) results of MINT™ (Minimally Invasive Nasal Trabeculostomy) operation in open angle Glaucoma Caucasian patients.
Department of ophthalmology, Malayan medical center, Yerevan, Armenia. Interim results from an ongoing, prospective, one surgeon, single-arm study.
The MINT™ device (Sanoculis, Israel) automatically creates round openings in the functional trabecular meshwork by an ab-interno approach. Sixty six operations were done on uncontrolled glaucomatous patients, of which 25 cases have completed a 6 months follow-up period.
N=58, follow-up: 6 months, surgery length: 3:00±1:33 minutes, preoperative IOP (intraocular pressure) 22.8±1.5 mmHg, postoperative IOP 15.0±2.8 mmHg, reduction in IOP 34.2%, reduction in medications 77.8% (from 0.9±0.8 to 0.2±0.5), reversible adverse events 0%, irreversible adverse events 0%, qualified success 84.4% (49/58), complete success 77.8% (45/58). Success rate (FDA definition): at least 20% reduction in IOP on same number or less (qualified success) or no (complete success) medications.
The new minimally invasive, automatic trabeculostomy procedure, done with the MINT™ surgical device, was found safe and quite efficacious in uncontrolled open angle glaucoma patients. The results so far are similar to other trabecular by-pass procedures; however the MINT™ procedure is simpler and quicker.